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1. Introduction 
It is widely acknowledged that cancers are disorders of cell growth and behavior and that 
its cause has to be defined at cellular levels. However, studies have shown that the cause 
of cancer can be deduced from a study of its epidemiology. Sir Percival Pott is credited 
with linking chemicals to causing cancer when he observed astutely that Chimney 
sweeps, because of their chronic exposure to sooth, were prone to scrotal cancers. 
Subsequently, the Danish Chimney sweeps guild ruled that its members must have their 
bath daily and this prevented the problem.1 Prior to this, John Hill had linked nasal 
polyps to “immoderate use of snuff”. Epidemiology has also contributed in linking 
cervical cancer to human papilloma viruses and radiation to different cancers1. It is also 
important for the purposes of health planning and allocation of resources to know the 
distribution of any particular disease. 
Retinoblastoma, an embryonal tumour originating from retinal cells, is reputed to be the 
commonest intraocular malignancy in children.  Currently, retinoblastoma is the most 
common solid tumour in children after brain/nervous system tumours and lymphomas in 
the United Kingdom.2 Kramarova and Stiller also reported a similar pattern among 
American children.3 In Nigeria, retinoblastoma is second only to lymphoma in most 
studies4,5,6  and third in some series.7 Report from other African countries shows that this 
tumour is the second most common childhood solid tumour.8  
2. Age distribution 
Age has an important influence on the likelihood of beings afflicted with cancer. The 
incidence of cancer rises with advancing age and most cases occur in people aged 55years 
and above. The age related rising incidence may be explained by the accumulation of 
mutations associated with the emergence of cancers. Most cases of retinoblastoma, however, 
occur in childhood with over 90% being diagnosed before five years of age; only 24 cases 
have been reported in adults aged between 20years and 74 years.9 The worldwide incidence 
rate of retinoblastoma for children aged 0-4years varies from 3.4% per million in Bulgaria10 
to a very high 42.5 per million in Mali.11 Incidence rates vary greatly in some regions while it 
varies only slightly in some other regions (table 1).  
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Region Incidence 
Australia 1.4 
Belgium 1 
Canada 2 
Croatia 0.7 
Czech Republic 0.7 
Denmark 1.3 
Estonia 1.5 
Finland 1.1 
France 1.6 
Germany 2.3 
1celand 1.1 
Ireland 1.0 
Italy 1.4 
Latvia 0.2 
Lithuania 1.4 
Malta 1.9 
New Zealand 2.2 
Norway 0.7 
Poland 0.6 
Portugal 3.6 
Russia 1.3 
Slovakia 1.5 
Slovenia 1.0 
Sweden 3.5 
Switzerland 1.7 
The Netherlands 1.2 
United Kingdom 1.3 
United States White 1.4 
United States Hispanic 1.4 
Yugoslavia o.2 
Table 1. Average incidence for whites in the United States and Nations with greater than 
85% White population (adapted from J Pediatr Ophthalmol Strabismus 2009 ;46: 288-293) 
A large study in the USA12 covering a 30year period from1975 – 2004 using the 
Surveillance Epidemiology and End Results (SEER) programme database of the National 
Cancer Institute found 658 of retinoblastoma cases over the period. The overall mean 
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adjusted incidence was 11.3 for males and 12.4 for females. Seventy two per cent (72%) 
were unilateral while 27% were bilateral. In 1% of cases the laterality was unknown. With 
increasing age at diagnosis, the bilateral tumours decreased significantly.  However, the 
percentage of unilateral tumours increased with increasing age at diagnosis. The overall 
incidence of retinoblastoma also reduced with increasing age (Figure 1). Bilateral new 
cases are not seen after the age of 3years. The peak age of presentation for both bilateral 
and unilateral retinoblastoma in the USA is before one year of age. Thereafter, the 
incidence reduced steeply with age. Only 4.3% of new cases of retinoblastoma were seen 
between the ages of 5-9years in this study.  
 
Fig. 1. Distribution of retinoblastoma by age at diagnosis (Adapted from Br J Ophthalmol 2009; 
93: 21-23)  
Another work in the USA13 from 1993 to 1997 using data from the international agency for 
cancer found a rate incidence of 4.4 per million for white children with most of the other 
findings similar to the findings by Broaddus et al.12  
In Great Britain,14 retinoblastoma affects approximately 1 in 20000 children. The bilateral 
cases make up 36% of the total cases. In this study in the UK, using the National Registry for 
Childhood Tumours (NRCT), the peak incidence was in children below one year, similar to 
findings in USA studies. After the age of one year, the incidence reduced steadily. Children 
older than four years made up less than 5% of new cases. The peak age for unilateral cases is 
in the two year age group while that of bilateral cases is before the first birthday. British 
studies have shown that unilaterality does not rule out heredity. In this series reported by 
MacCarthy et al, almost 11% of the unilateral retinoblastoma was heritable cases. All the 
bilateral cases are usually heritable.  
A Swedish and Finish15 study covering 1958 to 1998 using data from cancer registries and 
corresponding national referral centers for retinoblastoma found 0-13 and 0-10 new cases 
per year in Sweden and Finland respectively. The incidence rates per million children under 
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5years in Sweden and Finland was 11.8 and 11.2 respectively. In this study 90-96% of all 
retinoblastomas were diagnosed in children less than 5 years.  
In Pakistani studies,16 between 1999 and 2002 found 70 retinoblastoma cases, with 93% of 
them in children below 5years; 67% of the cases were bilateral. Bilateral cases became less 
prevalent with increasing age while the unilateral cases peaked in the 2-3year age group 
with a gradual decline thereafter. The mean at presentation is 28.17 months, unilateral cases 
having a mean age of 31.81 months. In China,17 a study covering 1957 to 2006 found that 
1234 eyes were enucleated due to retinoblastoma in a specialist eye hospital.  The mean age 
was 2.8years with a range of 1 month to 14years. Bilateral tumours accounted 2.4% of cases, 
an interesting finding. This was attributed to the nature of their study.  
In South Africa,18 a study by Freedman and Goldberg in 1976 covering a 20-year period in a 
specialist eye Hospital found 71 cases out of which 82% were unilateral and the other 18% 
bilateral. The average of the unilateral cases was 3½ years while while for the bilateral, it 
was 3years, much higher than the findings in western industrialized countries; 80% of cases 
were diagnosed before the age of 4years. 
In a Congolese19 study carried out in a teaching Hospital on Congolese blacks over a 
58month period found 21% bilateral cases. The mean age for all cases was 2.94years with a 
4months to 6years. The mean age for the bilateral cases was 1.12years. The mean age in 
other African studies ranged from 24months to 44months.20,21,22,23 The relatively advanced 
age of presentation in African series has been attributed very late presentation. The 
African patients may seek alternative means of healing before coming to hospital. 
Incidence studies in Africa put the incidence estimates at 20 cases per million in Malawi24 
and 9.3 per million in Guinea Conakry.25 These are much higher than rates in USA. This 
has been attributed to some unknown environmental influences and the higher birth rates 
in Africa.  
In Nigeria, retinoblastoma is the commonest childhood intraocular malignancy with a mean 
age at presentation of 29 months. For bilateral retinoblastoma which accounted for 13% of 
cases, the mean age at presentation was younger at 15 months.26 
3. Sex distribution 
Most studies from different parts of the world suggest no sex discrepancy in the incidence of 
retinoblastoma. In the USA, studies by different workers12,13 have found an age adjusted 
incidence of 11.3 for males and 12.4 for females suggesting a mild female predominance. 
This difference however was not significant.  
In Mexico,27 a study carried out in sixteen centers over a 5-year period showed a non 
significant mild male predominance of 1.1: 1.0 for all the cases seen. These studies do not 
show any breakdown of the sex distribution between the age groups and between the 
unilateral, bilateral and other types of retinoblastoma.  
In Great Britain, the study by MacCarthy et al14 showed that overall, males and females had 
no difference in the distribution of retinoblastoma for all ages. However, for the 0-1year age 
group in bilateral retinoblastoma category, there is a 1.1: 1.0 male predominance. For the 1-2 
year age group, the male: female predominance for the bilateral tumours is 1.3: 1.0 while for 
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the 2-3year age group, it is 2.2: 1.0. All other age groups showed no significant M:F 
difference in the incidence of bilateral retinoblastoma. For bilateral tumours for all ages, the 
M:F ratio 1.3: 1.0. 
In Pakistan, Arif Mohamed et al16 found an equal sex distribution for retinoblastomas in 
childhood. There was also no gender difference between the unilateral and the bilateral 
cases. 
In China,17 between the years 1977 to 1996, there was a marked male predominance of 3: 2 
and an insignificant overall male predominance of 2.6: 2.0. As in many other studies, the sex 
distribution between the unilateral and bilateral tumours is not stated.  
In Southern Africa studies,18 there is a marked male predominance over females (3:1) in the 
bilateral cases. However, for the unilateral cases, the ratio of males to females is 1.2: 1.0. For 
the1-2year age group, the M: F ratio is about 2: 1. Overall however the M: F ratio is 4:3.  
Studies from Congo19 show a M: F predominance for all cases of retinoblastoma seen over a 
6year period to be 2:1. Some other African studies show a male: female ratio of 1.120,21  
In Ilorin, Nigeria,26 there was a mild female predominance of 1.2: 1 overall. The mean age for 
females and males was also not significant at 31 months and 27 months respectively. 
However, Akang et al20 from Ibadan, Nigeria reported a female predominance of 3:2. 
4. Geographical/racial distribution 
Retinoblastoma has a worldwide distribution. It has been reported from different parts of 
the world. Because the pathogenesis of retinoblastoma is linked with genetic alterations in 
the tumour suppressor Rb gene on chromosome 13q14, one would expect a racial 
variation.  
A study by Krishna et al28 covering a 7year period between 1993 and 1997 and using data 
from International agency for Research on Cancer, a comparison of the racial and 
geographic incidence patterns of retinoblastoma in North America, South America, Oceania 
and Eroupe was carried out. This, to our knowledge, is the most comprehensive that 
attempts to find a racial and geographic pattern in the incidence of retinoblastomas. This 
work found a higher incidence of retinoblastoma in Hispanics in the USA than in white 
children in 3 areas- Los Angeles, San Francisco and New Mexico. However, when 
adjustments were made and comparison with White population was made, there was no 
significant difference. This was interpreted to mean that retinoblastoma was similar in 
White and Hispanic populations in the United States. However, Pendergrass and Davis12 
and Howe et al29 had found higher rates in Hispanic population over the White population. 
The consensus, however, is that the perceived difference can be attributed to confounding 
factors such as cancer registration practices or number of cases. In this study, the rate of 
retinoblastoma in whites in Europe was found to be the same as in Whites in USA. There 
was also no significant difference in the incidence in White populations in Oceania and 
USA. It was only the rates in Portugal and Sweden that were significantly higher than rates 
in the US Whites. This was attributed to cancer reporting practices30. The rates in Canada 
were similar to that in USA. The Broaddus et al study12 in USA also showed no significant 
difference between Whites and Blacks in the USA.  
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Comparing the incidence of retinoblastoma in Africans with that of other advanced 
countries is difficult because calculating rates in Africans countries is fraught with problems. 
However, rates of up to 20 per million children under five24 9.3 per million age standardized 
in Guinea Conakry25 have been noted. These would suggest that the rates are much higher 
in Africa than the rest of the world. This has been attributed to ignorance, poor health 
facilities and high birth rates. What, however, is certain is that African retinoblastomas are 
diagnosed at a significantly later age than in the advanced world. 
5. Summary 
Retinoblastoma is a childhood cancer with 90% diagnosed before the age five years. Only 24 
cases have been reported in adults between 20-74 years worldwide. Unilateral cases are 
commoner than bilateral cases in a ratio of 2.7: 1. With increasing age at diagnosis, unilateral 
cases increased significantly while the bilateral cases decreased significantly. However, the 
overall incidence of retinoblastoma decreases with advancing age. The peak age of 
presentation is before the age of one year in advanced countries but between the ages of two 
and three years in Africa due to late presentation. Although many studies show a mild 
female predominance, this is not significant. However, some European studies note a 
significant male predominance for bilateral tumours and retinoblastoma diagnosed in the 
two to three year age group.  
The incidence rate varies worldwide with higher levels in Africa and much lower levels in 
Europe. However, in multiracial countries like the USA, no significant difference between 
races was found 
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